hVIVO plc (LON:HVO – Get Free Report)’s share price traded down 7.6% during mid-day trading on Wednesday . The company traded as low as GBX 22 ($0.28) and last traded at GBX 22 ($0.28). 2,996,261 shares changed hands during mid-day trading, a decline of 15% from the average session volume of 3,527,909 shares. The stock had previously closed at GBX 23.80 ($0.30).
hVIVO Trading Down 1.0 %
The business’s 50 day moving average is GBX 27.82 and its 200 day moving average is GBX 28.04. The stock has a market cap of £154.25 million, a price-to-earnings ratio of 765.00 and a beta of 0.97. The company has a debt-to-equity ratio of 33.86, a current ratio of 1.61 and a quick ratio of 1.16.
About hVIVO
hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.
Read More
- Five stocks we like better than hVIVO
- The Risks of Owning Bonds
- Why Palo Alto Networks’ Multi-Year Uptrend Is Far From Over
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- 3 Rock-Solid Buying Opportunities in the Market Right Now
- How Technical Indicators Can Help You Find Oversold Stocks
- TJX Companies Stock Poised to Hit a New High This Year
Receive News & Ratings for hVIVO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for hVIVO and related companies with MarketBeat.com's FREE daily email newsletter.
